Drug Shortage Report for MYLAN-ATAZANAVIR

Last updated on 2022-05-31 History
Report ID 161593
Drug Identification Number 02456885
Brand name MYLAN-ATAZANAVIR
Common or Proper name ATAZANAVIR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATAZANAVIR
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 60BT
ATC code J05AE
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-03
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-05-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-05-31 French Compare
v1 2022-05-31 English Compare

Showing 1 to 2 of 2